AlisonMBoyceMD

PubMed

• 66 citations
  The Utility of DXA Assessment at the Forearm, Proximal Femur, and Lateral Distal Femur, and Vertebral Fracture Assessment in the Pediatric Population: 2019 ISCD Offici...
  David R. Weber, Alison M. Boyce, Catherine M. Gordon, Wolfgang Högler, Heidi H. Kecskemethy
  Journal of Clinical Densitometry. 2019-10-01
• 164 citations
  Denosumab Treatment for Fibrous Dysplasia
  Alison M. Boyce, William H. Chong, Jack Yao, Rachel I Gafni, Marilyn H. Kelly
  Journal of Bone and Mineral Research. 2012-07-01
• 46 citations
  Characterization and Management of Testicular Pathology in McCune-Albright Syndrome
  Alison M. Boyce, William H. Chong, Thomas H. Shawker, Peter A. Pinto, W. Marsten Linehan
  The Journal of Clinical Endocrinology and Metabolism. 2012-06-22

Journal Articles

• Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated with Disease Burden  
  Alison M Boyce, Jeffrey Tsai, Rachel I Gafni, Journal of Bone and Mineral Research
• Fibrous Dysplasia/McCune-Albright Syndrome 2015 Feb 26 In: Pagon RA, Adam MP, Amemiya A, et al, editors  
  Boyce AM, Collins MT, GeneReviews, 1/1/2015
• Oral pigmentation in McCune-Albright syndrome  
  Pichard DC, Boyce AM, Collins MT, Cowen EW, JAMA Dermatology, 1/1/2014
• Rare bone diseases and their dental, oral, and craniofacial manifestations  
  Foster BL, Ramnitz MS, Gafni RI, Burke AB, Boyce AM, Lee JS, Wright JT, Akintoye SO, Somerman MJ, Collins MT, Journal of Dental Research, 1/1/2014
• Bisphosphonate treatment in children with disabling conditions  
  Boyce AM, Tosi LL, Paul SC, Physical Medicine and Rehabilitation, 1/1/2014
• Multi-lineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23, and hypophosphatemia  
  Young HL, Ovejero D, Sugarman JS, DeKlotz CM, Maruri A, Eichenfield LF, Kelley PK, Juppner H, Gottschalk M, Tifft CJ, Gafni RI, Boyce AM, Cowen EW, Bhattacharyya N, Gu..., Human Molecular Genetics, 1/1/2014
• Disease severity and functional factors associated with walking performance in polyostotic fibrous dysplasia of bone  
  Paul SM, Gabor LR, Rudzinski S, Giovanni D, Boyce AM, Kelly MR, Collins MT, Bone, 1/1/2014
• Effects of denosumab treatment and discontinuation on human growth plates  
  6. Wang H, Boyce AM, Tsai JY, Gafni RI, Farley FA, Kasa-Vubu JZ, Molinolo AA, Collins MT, Journal of Clinical Endocrinology and Metabolism, 1/1/2014
• Radiographic classification of femoral deformities in polyostotic fibrous dysplasia  
  Ippolito E, Farsetti P, Corsi A, Boyce AM, De Maio F, Collins MT, Clinical Orthopaedics and Related Research, 1/1/2014
• Acromegaly and McCune-Albright syndrome  
  Salenave S, Boyce AM, Collins MT, Chanson P, Journal of Clinical Endocrinology and Metabolism, 1/1/2014
• A randomized, double-blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia  
  Boyce AM, Kelly MH, Brillante BA, Kushner H, Weintroub S, Riminucci M, Bianco P, Robey PG, Collins MT, Journal of Clinical Endocrinology and Metabolism, 1/1/2014
• Tumor localization and biochemical response to cure in tumor-induced osteomalacia  
  Chong WH, Andreopoulou A, Chen CC, Reynolds J, Guthrie L, Kelly MH, Gafni RI, Bhattacharyya N, Boyce AM, El-Maouche D, Crespo DO, Sherry R, Chang R, Wodajo FM, Klet..., Journal of Bone and Mineral Research, 1/1/2013
• Ultrasound is superior to computed tomography for assessment of nephrocalcinosis in hypoparathyroidism  
  Boyce AM, Shawker TH, Hill SC, Choyke PL, Hill MC, James R, Yovetich NA, Collins MT, Gafni RI, Journal of Clinical Endocrinology and Metabolism, 1/1/2013
• Optic neuropathy in McCune-Albright syndrome: emphasis on early diagnosis and treatment of growth hormone excess  
  Boyce AM, Glover M, Kelly MH, Brillante BA, Butman JA, Fitzgibbon EJ, Brewer CC, Zalewski CK, Cutler CM, Kim HJ, Collins MT, Journal of Clinical Endocrinology and Metabolism, 1/1/2013
• Dental perspectives in fibrous dysplasia and McCune-Albright syndrome  
  Akintoye SO, Boyce AM, Collins MT, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 1/1/2013
• Fibrous dysplasia and fibroblast growth factor-23 regulation  
  Boyce AM, Bhattacharyya N, Collins MT, Current Osteoporosis Reports, 1/1/2013
• Characterization and management of testicular pathology in McCune-Albright syndrome  
  Boyce AM, Chong WH, Linehan WM, Pinto PA, Bhattacharyya N, Merino M, Shawker TH, Singer FR, Collins MT, Journal of Clinical Endocrinology and Metabolism, 1/1/2012
• Neuroendocrine ACTH-producing tumor of the thymus – experience with 12 patients over 25 years  
  Neary NM, Lopez-Chavez A, Abel BS, Boyce AM, Schaub N, Kwong K, Stratakis CA, Moran CA, Giaccone G, Nieman LK, Journal of Clinical Endocrinology and Metabolism, 1/1/2012
• Denosumab treatment for fibrous dysplasia  
  Boyce AM, Chong WH, Yao J, Kelly MH, Chamberlain C, Gafni RI, Molinolo AA, Cherman N, Bhattacharyya N, Ellsworth M, Kasa-Vubu JZ, Collins MT, Journal of Bone and Mineral Research, 1/1/2012
• Approach to the child with fractures  
  Boyce AM, Gafni RI, Journal of Clinical Endocrinology and Metabolism, 1/1/2011
• Join now to see all

Books/Book Chapters

• Fibrous Dysplasia 
  Boyce AMEditors: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO.MDText.com, Inc, South Dartmouth, MA2015
• The 5-Minute Pediatric Consult Standard 
  Chapter: Rickets/Osteomalacia 
  Page 794 - 795Boyce AM, Tosi LLEditors: Michael D. Cabana.Wolters Kluwer, Philadelphia, PAEdition 7th,2015
• Pediatric ESAP 2015-2016: Pediatric Endocrine Self-Assessment Program 
  Gafni RI, Alter CA, Bauer AJ, DeBoer M, Boyce AM, Huang SA, LaFranchi SH, Lekarev O, Miller BS, Palma Sisto PA, Silverman L, Stratakis CA, Thornton PS, Weinzimer SAEndocrine Society, Washington, DC2015
• Influence of Sex and Gender on Disease Expression and Treatment 
  Chapter: Sexual Dimorphism in Metabolic Bone Disorders 
  Tosi LL, O’Connor MI, Boyce AM2013
• A Clinical Approach to Endocrine and Metabolic Diseases 
  Chapter: Child with fractures 
  Page 308 - 322Boyce AM, Gafni RIEditors: Leonard Wartofsy.The Endocrine Society, Chevy Chase, MDEdition 2nd,2012
• Join now to see all

Abstracts/Posters

• Parathyroid Hormone (PTH) 1-34 therapy decreases urinary citrate in hypoparathyroidism
  Gafni RI, Langman C, Guthrie LC, Brillante BA, James R, Yovetich N, Boyce AM, Collins MT, American Society for Bone and Mineral Research, Seattle, WA, 1/1/2015
• A subtronchanteric femoral stress fracture following bisphosphonate treatment in an adolescent girl
  Boyce AM, Tosi LL, Gafni RI, International Conference on Children’s Bone Health; American Society for Bone and Mineral Research, Salzburg, Austria, 2015; Seattle, WA, 2015, 1/1/2015
• Long-term outcomes of surgical treatment for craniofacial fibrous dysplasia
  Boyce AM, Burke A, Cutler C, Dufresne C, Collins MT, International Conference on Children’s Bone Health; American Society for Bone and Mineral Research, Salzburg, Austria, 2015; WA, DC, 2015, 1/1/2015
• Implications for the future of pediatric and adolescent girls with McCune-Albright syndrome: Long-term obstetrical and gynecologic outcomes
  Casey RK, Boyce AM, Estrada A, Guthrie LC, Brillante BA, Gafni RI, Gomez-Lobo V, Collins MT, North American Society for Pediatric and Adolescent Gynecology Annual Clinical and Research Meeting, Orlando, FL, 1/1/2015
• Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome
  Estrada A, Boyce AM, Shawker T, Brillante BA, Guthrie LC, Gafni RI, Collins MT, Endocrine Society Meeting, San Diego, CA, 1/1/2015
• Striking response of tumor-induced osteomalacia to the FGFR inhibitor NVP-BGJ398
  Collins MT, Bergwitz C, Aitcheson G, Blau J, Boyce AM, Gafni RI, Guthrie LC, Miranda F, Slosberg E, Graus Porta D, Hopmann C, Welaya K, Isaacs R, Miller C, American Society for Bone and Mineral Research, Seattle, WA, 1/1/2015
• RANKL inhibition in the pathogenesis and treatment of fibrous dysplasia
  Burke A, Wang HD, Tsai J, Bhattacharyya N, Boyce AM, Gafni RI, Estrada A, Molinolo AA, Robey PG, Collins MT, American Society for Bone and Mineral Research Meeting, Houston, TX, 1/1/2014
• Cutaneous Skeletal Hypophosphatemic Syndrome: A new syndrome of FGF23 excess
  Ovejero D, Lim YL, Juppner H, Gottschalk M, Tifft CJ, Gafni RI, Boyce AM, Cowen EW, Guthrie LC, Gahl WA, Golas G, Loring EC, Overton JD, Mane SM, Lifton RP, Levy ML, C..., American Society for Bone and Mineral Research Meeting, Baltimore, MD, 1/1/2013
• A randomized, double-blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone
  Boyce AM, Kelly MH, Brillante BA, Kushner H, Wientroub S, Riminucci M, Bianco P, Robey PG, Collins MT, International Conference on Children’s Bone Health; American Society for Bone and Mineral Research, Rotterdam, The Neatherlands, 2013; Baltimore, MD, 2013, 1/1/2013
• Testicular tumors in children and young adults presenting with a known genetic syndrome are rarely malignant but require follow-up and occasionally medical treatment: ...
  Lodish MB, Gourgari E, Batista DL, Lyssikatos C, Crocker MK, Nandagopal R, Boyce AM, Collier S, Leschek EW, Merke DP, Collins MT, Carney JA, Stratakis CA, Endocrine Society Meeting, San Francisco, CA, 1/1/2013
• RANKL, OPG, and denosumab in fibrous dysplasia
  Tsai J, Bhattacharyya N, Chong WH, Boyce AM, Gafni RI, Molinolo AA, Robey PG, Collins MT, American Society for Bone and Mineral Research Meeting, Minneapolis, MN, 1/1/2012
• Cushing syndrome associated with McCune-Albright syndrome - long-term treatment with metyrapone
  Chang YT, Boyce AM, Collins MT, Pediatric Endocrine Society Meeting, Boston, MA, 1/1/2012
• The role of RANKL and RANKL inhibition in fibrous dysplasia
  Tsai J, Bhattacharyya N, Chong WH, Boyce AM, Molinolo AA, Robey PG, Collins MT, American Association for Dental Research Meeting, Tampa, FL, 1/1/2012
• A novel GALNT3 mutation associated with an unusually severe case of familial tumoral calcinosis
  Del-Rivero J, Chong WH, El-Maouche D, Wodajo FM, Bhattacharyya N, Gafni RI, Boyce AM, Brillante BA, Trivedi AN, Wang R, Sibley C, Chen M, Molinolo AA, Heller T, Goldba..., Endocrine Society Meeting, Houston, TX, 1/1/2012
• Ultrasound is superior to computed tomography for diagnosis of nephrocalcinosis in hypoparathyroidism
  Boyce AM, Shawker TH, Hill SC, Choyke P, Hill MC, James R, Yovetich NA, Collins MT, Gafni RI, Endocrine Society Meeting, Houston, TX, 1/1/2012
• Leydig cell hyperplasia is the predominant testicular phenotype in McCune-Albright syndrome
  Boyce AM, Chong WH, Shawker TH, Pinto PA, Linehan WM, Merino MJ, Singer FR, Collins MT, Endocrine Society Meeting, Houston, TX, 1/1/2012
• Denosumab treatment for fibrous dysplasia of bone
  Boyce AM, Yao J, Kelly MH, Chamberlain C, Chong WH, Gafni RI, Molinolo AA, Cherman N, Bhattacharyya N, Ellsworth M, Kasa-Vubu JZ, American Society for Bone and Mineral Research Meeting, San Diego, CA, 1/1/2011
• Utility of FGF23 venous sampling in a child with hypophosphatemic rickets
  Kletter GB, Dales MC, Shorr SS, Boyce AM, Chong WH, Wodajo FM, Chang R, Chen C, Collins MT, Endocrine Society Meeting, Boston, MA, 1/1/2011
• A novel syndrome of neurocutaneous melanosis, FGF23-mediated hypophosphatemic rickets, and a mosaic skeletal dysplasia
  Boyce AM, Chong WH, Kelly MH, Gafni RI, Cowen EW, Thornton PS, Collins MT, Endocrine Society Meeting, Boston, MA, 1/1/2011
• Neuroendocrine ACTH producing carcinoma of the thymus – experience with 10 patients
  Neary NM, Lopez-Chavez A, Boyce AM, Abel BS, Stratakis CA, Giaccone G, Nieman LK, Endocrine Society Meeting, San Diego, CA, 1/1/2010
• Join now to see all

Lectures

• Management of Pediatric Fibrous Dysplasia/McCune-Albright Syndrome 
  Oxford, United Kingdom - 1/1/2015
• Endocrine Complications of Fibrous Dysplasia/McCune-Albright Syndrome 
  Oxford, United Kingdom - 1/1/2015
• Meet the Expert Session: Managing Fibrous Dysplasia 
  Salzburg, Austria - 1/1/2015
• What is Fibrous Dysplasia/McCune-Albright Syndrome? 
  Fort Wayne, IN - 1/1/2015
• Pain in Fibrous Dysplasia/McCune-Albright Syndrome 
  Chicago, IL - 1/1/2015
• Pain and Quality of Life in Hypophosphatasia 
  Chicago, IL - 1/1/2015
• Molecular Biology and Medical Management of Fibrous Dysplasia/McCune-Albright Syndrome 
  Chicago, IL - 1/1/2015
• Medical Treatments for Fibrous Dysplasia/McCune-Albright Syndrome 
  Turin, Italy - 1/1/2014
• Bisphosphonate and Densosumab Treatment for Fibrous Dysplasia 
  New York, NY - 1/1/2014
• Endocrine Complications of Fibrous Dysplasia 
  New York, NY - 1/1/2014
• Pain and Quality of Life in Fibrous Dysplasia/McCune-Albright Syndrome 
  Chicago, IL - 1/1/2013
• Vitamin D Deficiency: What Every Pediatrician Needs to Know 
  Silver Spring, MD - 1/1/2013
• Join now to see all

Other

• Fibrous Dysplasia/McCune-Albright Syndrome 
  Boyce AM, Collins MT, The MAGIC Foundation for Children’s Growth
  http://www.magicfoundation.org/downloads/masbrochure2013.pdf
  1/1/2013